# Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS

> **NCT05710770** · NA · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 66 (actual)

## Conditions studied

- ME/CFS
- Post-COVID ME/CFS

## Interventions

- **DEVICE:** Immunoadsorption

## Key facts

- **NCT ID:** NCT05710770
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2025-08-04
- **Final completion:** 2025-10-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05710770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05710770, "Immunoadsorption in Patients With Chronic Fatigue Syndrome Including Patients With Post-COVID-19 CFS". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05710770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*